Skip to main content
. 2020 Nov 3;9(1):2404–2416. doi: 10.1080/22221751.2020.1838954

Figure 6.

Figure 6.

In vivo antiviral activity of MB against ZIKV. (A-C) Viremia was detected by plaque forming unit assay on day 3 post-infection of ZIKV with doses of 1.7 × 104 (A) or 1.7 × 105 (B-C) PFU/mouse in four-week-old A129 mice, which were treated with vehicle or MB though oral gavage. Difference between MB or vehicle treatment was analysed by using the unpaired, two-tailed T-test, *, P<0.05; **, P<0.005. N = 4 for A and B. For C, vehicle, N = 10; MB, N = 9.